Intuitive Surgical, Inc. $ISRG Stock Position Lessened by Moloney Securities Asset Management LLC

Moloney Securities Asset Management LLC decreased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 47.1% in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 709 shares of the medical equipment provider’s stock after selling 631 shares during the quarter. Moloney Securities Asset Management LLC’s holdings in Intuitive Surgical were worth $385,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently modified their holdings of the company. Chilton Capital Management LLC grew its stake in shares of Intuitive Surgical by 614.3% in the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 43 shares in the last quarter. Elite Financial Inc. bought a new position in shares of Intuitive Surgical in the first quarter worth $26,000. LFA Lugano Financial Advisors SA bought a new position in shares of Intuitive Surgical in the first quarter worth $30,000. TD Capital Management LLC lifted its holdings in shares of Intuitive Surgical by 300.0% in the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock valued at $30,000 after buying an additional 45 shares during the period. Finally, 1248 Management LLC acquired a new stake in shares of Intuitive Surgical in the first quarter valued at $30,000. Institutional investors own 83.64% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on ISRG. Hsbc Global Res upgraded Intuitive Surgical to a “strong-buy” rating in a report on Thursday. Royal Bank Of Canada set a $625.00 price objective on Intuitive Surgical and gave the company an “outperform” rating in a report on Wednesday. Leerink Partners upped their price objective on Intuitive Surgical from $593.00 to $600.00 and gave the company an “outperform” rating in a report on Wednesday. Robert W. Baird set a $655.00 price objective on Intuitive Surgical in a report on Wednesday. Finally, HSBC upped their price objective on Intuitive Surgical from $595.00 to $644.00 and gave the company a “buy” rating in a report on Thursday. One analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and an average price target of $602.32.

Insider Buying and Selling at Intuitive Surgical

In related news, insider Gary S. Guthart sold 29,360 shares of the company’s stock in a transaction on Friday, August 29th. The stock was sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the transaction, the insider directly owned 19,827 shares of the company’s stock, valued at approximately $9,368,059.23. The trade was a 59.69% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Amy L. Ladd sold 336 shares of the company’s stock in a transaction on Wednesday, September 3rd. The shares were sold at an average price of $470.11, for a total value of $157,956.96. Following the transaction, the director directly owned 1,074 shares in the company, valued at $504,898.14. The trade was a 23.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 40,724 shares of company stock worth $19,500,332 over the last three months. 0.70% of the stock is owned by insiders.

Intuitive Surgical Stock Down 0.9%

Shares of NASDAQ ISRG opened at $546.51 on Friday. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $616.00. The company has a market cap of $195.91 billion, a price-to-earnings ratio of 72.29, a P/E/G ratio of 5.45 and a beta of 1.61. The business has a fifty day simple moving average of $458.09 and a 200-day simple moving average of $497.29.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, beating the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The business had revenue of $2.51 billion during the quarter, compared to the consensus estimate of $2.41 billion. During the same period in the prior year, the business posted $1.84 earnings per share. Intuitive Surgical’s revenue was up 22.9% compared to the same quarter last year. As a group, sell-side analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.